Sabtu, 17 Oktober 2026 - 08:30 WIB
Find and Follow Us
emiten.org
Global Markets
IHSG 6,231.78 +0.00%
S&P 500 7,443.28 -0.19%
NASDAQ 25,508.07 -0.05%
Dow Jones 51,839.26 -0.59%
FTSE 100 10,524.80 -0.71%
CAC 40 8,340.11 +0.02%
Nikkei 225 65,193.75 +1.64%
Hang Seng 25,111.29 -0.13%
Shanghai 3,779.30 -0.45%
KOSPI 6,712.12 +3.01%
STI 5,513.85 +0.27%
ASX 200 8,766.60 -0.28%
Sensex 77,708.52 -0.57%
Gold 4,030.20 +0.44%
Silver 57.26 +2.17%
Oil (WTI) 82.30 -0.23%
Brent 88.63 +0.60%
Copper 6.37 +2.33%
Gas Alam 2.85 -2.27%
Bitcoin 65,194.22 +0.00%
Ethereum 1,906.44 +0.00%
USD/IDR 17,971.00 +0.21%
EUR/USD 1.14 -0.08%
Industry.co.id Logo
Uji klinis Daewoong Pharmaceutical
Hot News

Daewoong Pharmaceutical Mendukung Pakar Indonesia Merintis Uji Klinis Pengobatan GERD dengan Fexuprazan

Redaksi • 14 Agustus 2024

Latest Updates

Uji klinis Daewoong Pharmaceutical
21:19 WIB • 14 Agustus 2024
Daewoong Pharmaceutical Mendukung Pakar Indonesia Merintis Uji Klinis Pengobatan GERD dengan Fexuprazan

Tim yang terdiri dari Key Opinion Leaders (KOL) Indonesia yang terkemuka, dipimpin oleh ahli gastroenterologi ternama Prof.…